종양학 영양 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 암 유형별, 영양별, 유통 채널별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Oncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Cancer Type, By Nutrition, By Formula, By Distribution Channel, By End User, By Region & Competition, 2020-2030F
상품코드:1714235
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 종양학 영양 시장은 2024년 25억 3,000만 달러 규모에 달할 것으로 예상되며, 2030년에는 41억 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 8.35%의 CAGR로 성장할 것으로 예상됩니다.
이 시장은 전 세계 암 발병률의 증가, 암 치료 계획의 중요한 요소로서 영양에 대한 임상적 인식의 증가, 환자 중심의 전인적 치료 제공으로의 전환 등에 힘입어 역동적으로 성장하고 있습니다. 과거에는 보조적인 치료로 여겨졌던 종양학 영양은 이제 다학제적 치료 접근법에서 필수적인 역할을 담당하고 있습니다. 이러한 발전은 질환별 제제의 사용 증가, 치료 경로에서 영양의 제도적 표준화, 환자별 대사적 요구에 따른 정밀 영양에 의해 주도되고 있습니다. 영양 공급 및 실시간 건강 모니터링 분야의 기술 혁신은 보다 효과적인 개입을 가능하게 하고 제품 개발을 촉진하고 있습니다. 영양 지원과 치료 결과 개선의 연관성이 입증됨에 따라 시장은 일반적인 영양 지원에서 근거 기반 치료 솔루션으로 이동하고 있습니다. 이에 따라 암 환자의 임상 결과 개선, 비용 효율성 및 삶의 질 향상을 목표로 하는 기존 기업 및 신생 혁신 기업에게 큰 성장 잠재력이 생겨나고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
25억 3,000만 달러
시장 규모 : 2030년
41억 달러
CAGR : 2025-2030년
8.35%
급성장 부문
폐암
최대 시장
북미
시장 촉진요인
전 세계 암 발병률과 사망률 급증하는 추세
주요 시장 과제
규제의 복잡성
주요 시장 동향
영양유전체학의 부상
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 종양학 영양 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
암 종류별(폐암, 두경부암, 위·소화기암, 식도암, 간암, 혈액암, 기타)
영양별(경장영양, 정맥영양)
식별(표준식, 원소식, 특수식)
유통 채널별(병원 약국, 온라인 약국, 소매 약국)
최종사용자별(병원, 재택 케어, 전문 클리닉)
지역별
기업별(2024년)
시장 맵
제6장 북미의 종양학 영양 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 종양학 영양 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 종양학 영양 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 종양학 영양 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 종양학 영양 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
인수합병
제13장 세계의 종양학 영양 시장 : SWOT 분석
제14장 경쟁 구도
Abbott Laboratories Inc
Nestle SA
Fresenius Kabi AG
B Braun SE
Hormel Foods Corporation
Danone SA
MEIJI Holdings Co Ltd
Global Health Products, Inc.
Victus Inc
Mead Johnson & Co LLC
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Oncology Nutrition Market reached a value of USD 2.53 billion in 2024 and is projected to attain USD 4.10 billion by 2030, growing at a CAGR of 8.35% during the forecast period. This market is undergoing dynamic expansion fueled by the increasing global cancer burden, the heightened clinical recognition of nutrition as a key component in oncology treatment plans, and the transition toward holistic, patient-focused care delivery. Once seen as a supplementary practice, oncology nutrition now plays an essential role in multidisciplinary treatment approaches. This evolution is being propelled by the increased use of disease-specific formulations, institutional standardization of nutrition in care pathways, and precision nutrition guided by patient-specific metabolic needs. Technological innovations in nutrient delivery and real-time health monitoring are enabling more effective interventions and advancing product development. As the link between nutritional support and better treatment outcomes becomes more substantiated, the market is shifting from general nutritional support to evidence-based, therapeutic solutions. This creates substantial growth potential for established players and emerging innovators seeking to deliver enhanced clinical outcomes, cost efficiency, and improved quality of life for cancer patients.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.53 Billion
Market Size 2030
USD 4.10 Billion
CAGR 2025-2030
8.35%
Fastest Growing Segment
Lung Cancer
Largest Market
North America
Key Market Drivers
Surging Global Cancer Incidence and Mortality
The increasing global incidence and mortality rates associated with cancer are primary growth drivers for the oncology nutrition market. In 2022, around 20 million new cancer cases and 9.7 million cancer-related deaths were reported, emphasizing the urgent need for supportive care solutions. Approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting both improved survival and growing disease prevalence. Lifestyle-related risk factors-such as poor diet, sedentary habits, smoking, and alcohol consumption-as well as aging populations, continue to elevate cancer incidence, particularly in developed regions. Individuals aged 60-69 are four times more likely to be diagnosed with cancer than those under 50, while those over 70 face a tenfold increase in risk. The rising number of cancer diagnoses is directly increasing demand for comprehensive treatment support, including specialized nutritional interventions that can aid in managing side effects, boosting recovery, and enhancing treatment adherence.
Key Market Challenges
Regulatory Complexity
The oncology nutrition sector faces regulatory hurdles due to diverse and complex standards governing product development, labeling, and distribution across regions. Regulations vary significantly by country, and navigating this fragmented regulatory landscape is time-consuming and resource-intensive. Global companies must invest heavily in compliance to meet these evolving regulatory requirements, which can slow innovation and market expansion.
Key Market Trends
Rise of Nutrigenomics
Nutrigenomics-the study of how an individual's genetic makeup influences their response to nutrients-is gaining momentum in oncology nutrition. This approach enables highly personalized dietary plans that align with a patient's unique genetic and metabolic profile. It has the potential to revolutionize cancer care by improving treatment effectiveness, minimizing side effects, and enhancing overall outcomes through customized nutritional strategies rooted in precision medicine.
Key Market Players
Abbott Laboratories Inc
Nestle SA
Fresenius Kabi AG
B Braun SE
Hormel Foods Corporation
Danone SA
MEIJI Holdings Co Ltd
Global Health Products, Inc.
Victus Inc
Mead Johnson & Co LLC
Report Scope:
In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Oncology Nutrition Market, By Cancer Type:
Lung Cancer
Head and Neck Cancer
Stomach and Gastrointestinal Cancers
Esophageal Cancer
Liver Cancer
Blood Cancer
Others
Oncology Nutrition Market, By Nutrition:
Enteral Nutrition
Parenteral Nutrition
Oncology Nutrition Market, By Formula:
Standard Formula
Elemental Formula
Specialized Formula
Oncology Nutrition Market, By Distribution Channel:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Oncology Nutrition Market, By End User:
Hospitals
Homecare
Specialty Clinics
Oncology Nutrition Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.
Available Customizations:
Global Oncology Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Oncology Nutrition Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Oncology Nutrition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Cancer Type
6.2.2. By Nutrition
6.2.3. By Formula
6.2.4. By Distribution Channel
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Oncology Nutrition Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Cancer Type
6.3.1.2.2. By Nutrition
6.3.1.2.3. By Formula
6.3.1.2.4. By Distribution Channel
6.3.1.2.5. By End User
6.3.2. Canada Oncology Nutrition Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Cancer Type
6.3.2.2.2. By Nutrition
6.3.2.2.3. By Formula
6.3.2.2.4. By Distribution Channel
6.3.2.2.5. By End User
6.3.3. Mexico Oncology Nutrition Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Cancer Type
6.3.3.2.2. By Nutrition
6.3.3.2.3. By Formula
6.3.3.2.4. By Distribution Channel
6.3.3.2.5. By End User
7. Europe Oncology Nutrition Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Cancer Type
7.2.2. By Nutrition
7.2.3. By Formula
7.2.4. By Distribution Channel
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Oncology Nutrition Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Cancer Type
7.3.1.2.2. By Nutrition
7.3.1.2.3. By Formula
7.3.1.2.4. By Distribution Channel
7.3.1.2.5. By End User
7.3.2. United Kingdom Oncology Nutrition Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Cancer Type
7.3.2.2.2. By Nutrition
7.3.2.2.3. By Formula
7.3.2.2.4. By Distribution Channel
7.3.2.2.5. By End User
7.3.3. Italy Oncology Nutrition Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Cancer Type
7.3.3.2.2. By Nutrition
7.3.3.2.3. By Formula
7.3.3.2.4. By Distribution Channel
7.3.3.2.5. By End User
7.3.4. France Oncology Nutrition Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Cancer Type
7.3.4.2.2. By Nutrition
7.3.4.2.3. By Formula
7.3.4.2.4. By Distribution Channel
7.3.4.2.5. By End User
7.3.5. Spain Oncology Nutrition Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Cancer Type
7.3.5.2.2. By Nutrition
7.3.5.2.3. By Formula
7.3.5.2.4. By Distribution Channel
7.3.5.2.5. By End User
8. Asia-Pacific Oncology Nutrition Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Cancer Type
8.2.2. By Nutrition
8.2.3. By Formula
8.2.4. By Distribution Channel
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Oncology Nutrition Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Cancer Type
8.3.1.2.2. By Nutrition
8.3.1.2.3. By Formula
8.3.1.2.4. By Distribution Channel
8.3.1.2.5. By End User
8.3.2. India Oncology Nutrition Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Cancer Type
8.3.2.2.2. By Nutrition
8.3.2.2.3. By Formula
8.3.2.2.4. By Distribution Channel
8.3.2.2.5. By End User
8.3.3. Japan Oncology Nutrition Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Cancer Type
8.3.3.2.2. By Nutrition
8.3.3.2.3. By Formula
8.3.3.2.4. By Distribution Channel
8.3.3.2.5. By End User
8.3.4. South Korea Oncology Nutrition Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Cancer Type
8.3.4.2.2. By Nutrition
8.3.4.2.3. By Formula
8.3.4.2.4. By Distribution Channel
8.3.4.2.5. By End User
8.3.5. Australia Oncology Nutrition Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Cancer Type
8.3.5.2.2. By Nutrition
8.3.5.2.3. By Formula
8.3.5.2.4. By Distribution Channel
8.3.5.2.5. By End User
9. South America Oncology Nutrition Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Cancer Type
9.2.2. By Nutrition
9.2.3. By Formula
9.2.4. By Distribution Channel
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Oncology Nutrition Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Therapy
9.3.2. Argentina Oncology Nutrition Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Cancer Type
9.3.2.2.2. By Nutrition
9.3.2.2.3. By Formula
9.3.2.2.4. By Distribution Channel
9.3.2.2.5. By End User
9.3.3. Colombia Oncology Nutrition Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Cancer Type
9.3.3.2.2. By Nutrition
9.3.3.2.3. By Formula
9.3.3.2.4. By Distribution Channel
9.3.3.2.5. By End User
10. Middle East and Africa Oncology Nutrition Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Cancer Type
10.2.2. By Nutrition
10.2.3. By Formula
10.2.4. By Distribution Channel
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Oncology Nutrition Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Cancer Type
10.3.1.2.2. By Nutrition
10.3.1.2.3. By Formula
10.3.1.2.4. By Distribution Channel
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Oncology Nutrition Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Cancer Type
10.3.2.2.2. By Nutrition
10.3.2.2.3. By Formula
10.3.2.2.4. By Distribution Channel
10.3.2.2.5. By End User
10.3.3. UAE Oncology Nutrition Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Cancer Type
10.3.3.2.2. By Nutrition
10.3.3.2.3. By Formula
10.3.3.2.4. By Distribution Channel
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Oncology Nutrition Market: SWOT Analysis
